Emma Keane1,2, Isobel O'Riordan3, Thomas Crotty3, Justin M Hintze4, Edlir Shytaj4, Fergal O'Duffy3, Tadgh P O'Dwyer4, Tom Moran4,3. 1. St Vincent's University Hospital, Merrion Road, Dublin, Ireland. emmakeane@rcsi.ie. 2. ENT Department, Royal Victoria Eye and Ear Hospital, Adelaide Road, Dublin, Ireland. emmakeane@rcsi.ie. 3. Mater Misericordiae Hospital, Eccles Street, Dublin, Ireland. 4. St Vincent's University Hospital, Merrion Road, Dublin, Ireland.
Abstract
BACKGROUND: Transoral robotic surgery (TORS) has shown promising results in the treatment of myriad head and neck pathologies but is now most commonly used in the investigation and management of oropharyngeal squamous cell carcinoma. AIMS: The aim of this study was to report our cases of the newly introduced TORS, particularly its role in identifying primary of unknown origin and the potential implications for patients. A literature review and our early experience should begin to debunk some of the criticisms of TORS including setup times and cost. METHODS: Prospective data was collected from all patients undergoing transoral robotic surgery including demographics, indication, histology results in primary of unknown origin and complications. RESULTS: We have performed 36 TORS procedures in total ranging from intermediate to major complex. Our complication rate is low, and this has improved with the passage of time. Haemorrhage rates remain at 5.6% (n = 2), and the average length of stay is 1 day. Successful identification of a primary tumour in cancer of unknown primary was 80% (n = 8). CONCLUSIONS: We anticipate the integration of TORS into routine practice in the investigation and management of a number of ENT pathologies following robust clinical trials.
BACKGROUND: Transoral robotic surgery (TORS) has shown promising results in the treatment of myriad head and neck pathologies but is now most commonly used in the investigation and management of oropharyngeal squamous cell carcinoma. AIMS: The aim of this study was to report our cases of the newly introduced TORS, particularly its role in identifying primary of unknown origin and the potential implications for patients. A literature review and our early experience should begin to debunk some of the criticisms of TORS including setup times and cost. METHODS: Prospective data was collected from all patients undergoing transoral robotic surgery including demographics, indication, histology results in primary of unknown origin and complications. RESULTS: We have performed 36 TORS procedures in total ranging from intermediate to major complex. Our complication rate is low, and this has improved with the passage of time. Haemorrhage rates remain at 5.6% (n = 2), and the average length of stay is 1 day. Successful identification of a primary tumour in cancer of unknown primary was 80% (n = 8). CONCLUSIONS: We anticipate the integration of TORS into routine practice in the investigation and management of a number of ENT pathologies following robust clinical trials.
Authors: Andrey Finegersh; Floyd Christopher Holsinger; Neil D Gross; Ryan K Orosco Journal: Surg Oncol Clin N Am Date: 2018-10-23 Impact factor: 3.495
Authors: D Viros Porcuna; C Pollan Guisasola; C Viña Soria; B Cirauqui Cirauqui; L Pardo Muñoz; F Collurá; R Mesia Nin Journal: Clin Transl Oncol Date: 2019-12-19 Impact factor: 3.405
Authors: Thomas M Kaffenberger; Bradley Eichar; Katie S Traylor; Mark W Kubik; Barton F Branstetter Journal: Laryngoscope Date: 2020-08-17 Impact factor: 3.325